Authors: Byrd, JC Shinn, C Willis, CR Flinn, IW Lehman, T Suasville, E Lucas, D Gerver, MR

Citation: Jc. Byrd et al., UCN-01 induces cytotoxicity toward human CLL cells through a p53-independent mechanism, EXP HEMATOL, 29(6), 2001, pp. 703-708

Authors: Byrd, JC Grever, MR Waselenko, JK Willis, CR Park, K Goodrich, A Lucas, MA Shinn, C Flinn, IW

Citation: Jc. Byrd et al., Theophylline, pentostatin (Nipent), and chlorambucil: A dose-escalation study targeting intrinsic biologic resistance mechanisms in patients with relapsed lymphoproliferative disorders, SEMIN ONCOL, 27(2), 2000, pp. 37-40

Authors: Shinn, C Malhotra, D Chan, L Cosby, RL Shapiro, JI

Citation: C. Shinn et al., Time course of response to pulse methylprednisolone therapy in renal transplant recipients with acute allograft rejection, AM J KIDNEY, 34(2), 1999, pp. 304-307

Authors: Byrd, JC Shinn, C Ravi, R Willis, CR Waselenko, JK Flinn, IW Dawson, NA Grever, MR

Citation: Jc. Byrd et al., Depsipeptide (FR901228): A novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells, BLOOD, 94(4), 1999, pp. 1401-1408